David B. Roberts - 02 Jun 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jun 2022, 16:26:30 UTC
Prior SEC filing
28 Mar 2022
Next SEC filing
12 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

David B. Roberts filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 06 Jun 2022.

Key facts

  • This page summarizes David B. Roberts's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
  • 5 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 06 Jun 2022, 16:26.

Change

  • Previous filing in this sequence was filed on 28 Mar 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+1
Change %
+7.1%
Price
$0.000000
Shares after
15
Date
02 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
Footnotes
F1
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+2
Change %
+5.1%
Price
$0.000000
Shares after
41
Date
02 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2
Exercise price
Footnotes
F2
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+2
Change %
+8%
Price
$0.000000
Shares after
27
Date
02 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2
Exercise price
Footnotes
F3
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+3
Change %
+21%
Price
$0.000000
Shares after
17
Date
02 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3
Exercise price
Footnotes
F4
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+7
Change %
+100%
Price
$0.000000
Shares after
14
Date
02 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F2

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F3

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F4

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F5

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .